about
A large cell-adhesive scatter factor secreted by human gastric carcinoma cellsHyaluronan and a cell-associated hyaluronan binding protein regulate the locomotion of ras-transformed cellsThe crystal structure of a multifunctional protein: phosphoglucose isomerase/autocrine motility factor/neuroleukinThe role and clinical implications of G6PI in experimental models of rheumatoid arthritisThe crystal structure of phosphoglucose isomerase/autocrine motility factor/neuroleukin complexed with its carbohydrate phosphate inhibitors suggests its substrate/receptor recognitionThe autocrine motility factor receptor gene encodes a novel type of seven transmembrane proteinMolecular cloning of a novel hyaluronan receptor that mediates tumor cell motilityStimulation of tumor cell motility linked to phosphodiesterase catalytic site of autotaxinAnti-human immunodeficiency virus 1 (HIV-1) activities of 3-deazaadenosine analogs: increased potency against 3'-azido-3'-deoxythymidine-resistant HIV-1 strainsRaft-dependent endocytosis of autocrine motility factor/phosphoglucose isomerase: a potential drug delivery route for tumor cellsDrug development against metastasis-related genes and their pathways: A rationale for cancer therapyEffect of potent and selective inhibitors of the Grb2 SH2 domain on cell motility.Rapid chemokinetic movement and the invasive potential of lung cancer cells; a functional molecular study.Real-time quantitative measurement of autocrine ligand binding indicates that autocrine loops are spatially localized.A role for KAI1 in promotion of cell proliferation and mammary gland hyperplasia by the gp78 ubiquitin ligase.Monoclonal antibodies against autocrine motility factor suppress gastric cancer.Metabolic genes in cancer: their roles in tumor progression and clinical implicationsUtility of functional imaging in prediction or assessment of treatment response and prognosis following thermotherapy.Purification of the migration stimulating factor produced by fetal and breast cancer patient fibroblasts.Osteopontin knockdown suppresses the growth and angiogenesis of colon cancer cells.Purification of scatter factor, a fibroblast-derived basic protein that modulates epithelial interactions and movementSilencing of autocrine motility factor induces mesenchymal-to-epithelial transition and suppression of osteosarcoma pulmonary metastasis.Autocrine motility factor promotes HER2 cleavage and signaling in breast cancer cells.Glycolysis, tumor metabolism, cancer growth and dissemination. A new pH-based etiopathogenic perspective and therapeutic approach to an old cancer questionRole of myofibroblasts at the invasion front.Phosphoglucose isomerase/autocrine motility factor mediates epithelial-mesenchymal transition regulated by miR-200 in breast cancer cells.Integrating transcriptomics and proteomics to show that tanshinone IIA suppresses cell growth by blocking glucose metabolism in gastric cancer cells.Increased migration of human mesenchymal stromal cells by autocrine motility factor (AMF) resulted in enhanced recruitment towards hepatocellular carcinoma.Induction of epithelial to mesenchymal transition in PMC42-LA human breast carcinoma cells by carcinoma-associated fibroblast secreted factorsImproved prognosis assessment for patients with bladder carcinoma.Tumor autocrine motility factor responses are mediated through cell contact and focal adhesion rearrangement in the absence of new tyrosine phosphorylation in metastatic cells.Evodiamine Induces Apoptosis and Inhibits Migration of HCT-116 Human Colorectal Cancer CellsTargeted tumor therapy by Rubia tinctorum L.: analytical characterization of hydroxyanthraquinones and investigation of their selective cytotoxic, adhesion and migration modulator effects on melanoma cell lines (A2058 and HT168-M1).Glucose starvation and acidosis: effect on experimental metastatic potential, DNA content and MTX resistance of murine tumour cells.Expression of autocrine motility factor receptor correlates with disease progression in human gastric cancer.Signal transduction for chemotaxis and haptotaxis by matrix molecules in tumor cells.Scatter factor: molecular characteristics and effect on the invasiveness of epithelial cells.Interleukin 6 decreases cell-cell association and increases motility of ductal breast carcinoma cellsAutocrine motility factor receptor is a marker for a distinct membranous tubular organelle.AMF/PGI-mediated tumorigenesis through MAPK-ERK signaling in endometrial carcinoma
P2860
Q24563665-0022C8C0-7EFE-4176-A2DF-5015569897D5Q24644439-DB15CD26-539E-4D76-A840-FACFB0331AA3Q24683286-0EA40113-4BDA-43E2-A5E4-E85DEDBD2250Q24799403-419D1035-7360-4DA1-BEF0-24E0E1263244Q27622254-8C148BDC-35C7-4745-8C0B-86EEBE2C416AQ28142694-AB0CDCA2-D0E6-4395-A7DD-EE2EB8EF9E2FQ28187168-97FA3EA5-C3FB-40ED-AB4E-74A25804FDE2Q28289403-30BB6043-DE30-4270-B956-F4AF5FC199EBQ28368280-E3A8B1FC-F8FB-458A-901C-40C9BD85FEBAQ28473988-3AD4CFF9-DF00-4B7F-A3DA-0C5D15768F28Q29010479-351B3502-34F3-44C5-ACA7-FEE8FF832DE2Q30175384-09AE4B0C-83FD-4B11-ABB5-497081A4789BQ33245914-0B35C670-BDA2-4FF5-8325-3EFEA81D7C1DQ33584075-12EF973D-E545-4B9E-A5EC-10AF850B0D76Q33726482-0D44D0CD-24D0-4662-A541-C474464E10C8Q33751147-9E9792A7-EFF4-43D2-8B58-EAB02DD00A8BQ33772469-4D8002BC-605F-4CA3-B878-F7086AC28329Q33790254-78A294DF-C6D1-4ACD-8411-3F948F4987C3Q33848365-088FBCC2-06C9-438F-B369-C12EBEEAD2CEQ34036685-BFEFE6D5-4758-4ACC-B9FD-5D845F4D52D5Q34294357-A20A9277-C80E-4F30-9BF7-D858A55687BFQ34316283-F1383B7D-C1CE-4586-AD82-31D6F56650BDQ34318275-05128130-8F58-41FD-A176-EA964127BCD5Q34459681-C4B8B029-E8C1-4373-866E-9A8063C9C1FCQ34584808-4714570F-EC88-453D-9468-552BB8D53814Q34899974-E990A435-92CF-4553-9723-DE40DF8DA067Q35083386-6ACD69A6-267B-4960-B2F6-DAD08ABA69C8Q35149319-B081E243-89BB-4CAD-8EB4-F2144FF7A3DCQ35749344-16460E5A-E630-429C-B3A4-EC1FAD617782Q35764857-9CE62676-ED82-43C5-8DBF-742FA94F3945Q35773715-541D10CF-F915-4E65-AE5B-FE4B87157CA2Q35845158-ACC17EA2-E757-4CC9-A07D-42C8750D3660Q35874369-597B1C8E-C4E7-4B0B-AA2C-52692EAD3CD3Q35993893-8EF0B9ED-23E6-4ED4-B0AD-1B4EC7E75ECCQ36136383-A4782D27-55D4-46D9-85C2-5B35444DAC34Q36222822-E19636DD-6AFA-4BE0-AE6A-0259DF08CF1EQ36223889-CAC8B009-6126-415D-A4C5-76A3AD4ACB2FQ36357033-D5266A4F-3057-44C5-8D4C-67B406D9DA2EQ36382525-70E6C313-2DBC-4BEA-9768-78F1409978F3Q36413463-C66F7C9D-FE71-4074-A4F4-27AD2CEAA4BC
P2860
description
1986 nî lūn-bûn
@nan
1986 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1986 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1986年の論文
@ja
1986年論文
@yue
1986年論文
@zh-hant
1986年論文
@zh-hk
1986年論文
@zh-mo
1986年論文
@zh-tw
1986年论文
@wuu
name
Tumor cell autocrine motility factor
@ast
Tumor cell autocrine motility factor
@en
Tumor cell autocrine motility factor
@nl
type
label
Tumor cell autocrine motility factor
@ast
Tumor cell autocrine motility factor
@en
Tumor cell autocrine motility factor
@nl
prefLabel
Tumor cell autocrine motility factor
@ast
Tumor cell autocrine motility factor
@en
Tumor cell autocrine motility factor
@nl
P2093
P2860
P356
P1476
Tumor cell autocrine motility factor
@en
P2093
Schiffmann E
P2860
P304
P356
10.1073/PNAS.83.10.3302
P407
P577
1986-05-01T00:00:00Z